Showing 14,681 - 14,700 results of 106,156 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((point decrease) OR (a decrease)) ))', query time: 1.07s Refine Results
  1. 14681

    Young aphasia case study: Source localisation results of the context effect (constrained vs unconstrained naming) in A. and control by Vitoria Piai (9547418)

    Published 2022
    “…Power was thresholded at ±1.5. Corresponding Cohen’s d maps (bottom two rows) for control (third row) and A. …”
  2. 14682
  3. 14683
  4. 14684
  5. 14685

    ET-26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats by Bin Wang (30851)

    Published 2017
    “…</p><p>Methods</p><p>50% effective dose (ED<sub>50</sub>) and 50% lethal dose (LD<sub>50</sub>) were determined after single bolus doses of propofol, etomidate, or ET-26 HCl using the Bliss method and the up and down method, respectively. …”
  6. 14686
  7. 14687

    Table_5_Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial.docx by Mohammad Reza Aghasadeghi (9524778)

    Published 2024
    “…This study aimed to evaluate the efficacy and safety of high-dose Spirulina platensis for SARS-CoV-2 infection.</p>Study Design<p>We conducted a randomized, controlled, open-label trial involving 189 patients with COVID-19 who were randomly assigned in a 1:1 ratio to an experimental group that received 15.2g of Spirulina supplement plus standard treatment (44 non-intensive care unit (non-ICU) and 47 ICU), or to a control group that received standard treatment alone (46 non-ICU and 52 ICU). …”
  8. 14688
  9. 14689
  10. 14690

    Mendelian randomization results with COVID-19. by Alish B. Palmos (5857379)

    Published 2022
    “…The bottom section shows results consistent with five blood markers being significantly causally associated with an increased risk for the need of respiratory support/death due to COVID-19 and eight blood markers causally associated with a decreased risk for the need of respiratory support/death due to COVID-19, as well as one protein decreasing risk for the need of respiratory support/death due to COVID-19. …”
  11. 14691
  12. 14692

    Data_Sheet_1_A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis.PDF by Sofia Sandgren (17017017)

    Published 2023
    “…/mL (IQR 285.4) (p = 0.05); serum month 24: 6.7 pg/mL (IQR 4.7) (p < 0.01); serum month 60: 7.2 pg/mL (IQR 4.7) (p < 0.01)], compared to baseline [CSF: 1014 pg/mL (IQR 2832.5); serum 8.6 pg/mL (IQR 17.4)].</p>Conclusion<p>In this real-world mono-center population, we observed a progression-free survival of 69%, cumulative NEDA-3 of 33%, and reduced NfL levels, over a five-year follow-up. …”
  13. 14693
  14. 14694
  15. 14695
  16. 14696
  17. 14697
  18. 14698
  19. 14699

    <i>l</i>-THP decreased level of NO, ONOO<sup>−</sup> and iNOS, regulated expression of p85, eNOS and Akt. by Yi Han (194901)

    Published 2013
    “…(<b>g</b>) iNOS expression of myocardial I/R rats treated with vehicle and <i>l</i>-THP (M). iNOS expression was significantly decreased in <i>l</i>-THP (M)-treated group, <sup>###</sup>P<0.001 vs. sham group, *P<0.05 vs. vehicle group, n = 5. …”
  20. 14700